Viridian Therapeutics, Inc.VRDNNASDAQ
LOADING
|||
Cash Flow Performance
Above historical average, modest growth trend.
Left:
||||
Free cash flow yield
Latest
-17.89%
↑ 58% above average
Average (9y)
-42.72%
Historical baseline
Range
High:-7.73%
Low:-240.27%
CAGR
+9.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -17.89% | +5.8% |
| 2023 | -18.99% | -88.0% |
| 2022 | -10.10% | +56.7% |
| 2021 | -23.31% | +54.3% |
| 2020 | -50.96% | +78.8% |
| 2019 | -240.27% | -689.7% |
| 2018 | -30.43% | -114.9% |
| 2017 | -14.16% | -6.1% |
| 2016 | -13.34% | -72.5% |
| 2015 | -7.73% | - |